Peterman Scott M, Duczak Nicholas, Kalgutkar Amit S, Lame Mary E, Soglia John R
Thermo Electron Corporation, Somerset, New Jersey, USA.
J Am Soc Mass Spectrom. 2006 Mar;17(3):363-75. doi: 10.1016/j.jasms.2005.11.014. Epub 2006 Jan 25.
We report herein, facile metabolite identification workflow on the anti-depressant nefazodone, which is derived from accurate mass measurements based on a single run/experimental analysis. A hybrid LTQ/orbitrap mass spectrometer was used to obtain accurate mass full scan MS and MS/MS in a data-dependent fashion to eliminate the reliance on a parent mass list. Initial screening utilized a high mass tolerance ( approximately 10 ppm) to filter the full scan MS data for previously reported nefazodone metabolites. The tight mass tolerance reduces or eliminates background chemical noise, dramatically increasing sensitivity for confirming or eliminating the presence of metabolites as well as isobaric forms. The full scan accurate mass analysis of suspected metabolites can be confirmed or refuted using three primary tools: (1) predictive chemical formula and corresponding mass error analysis, (2) rings-plus-double bonds, and (3) accurate mass product ion spectra of parent and suspected metabolites. Accurate mass characterization of the parent ion structure provided the basis for assessing structural assignment for metabolites. Metabolites were also characterized using parent product ion m/z values to filter all tandem mass spectra for identification of precursor ions yielding similar product ions. Identified metabolite parent masses were subjected to chemical formula calculator based on accurate mass as well as bond saturation. Further analysis of potential nefazodone metabolites was executed using accurate mass product ion spectra. Reported mass measurement errors for all full scan MS and MS/MS spectra was <3 ppm, regardless of relative ion abundance, which enabled the use of predictive software in determining product ion structure. The ability to conduct biotransformation profiling via tandem mass spectrometry coupled with accurate mass measurements, all in a single experimental run, is clearly one of the most attractive features of this methodology.
我们在此报告一种简便的抗抑郁药奈法唑酮代谢物鉴定工作流程,该流程基于单次运行/实验分析的精确质量测量得出。使用混合线性离子阱/轨道阱质谱仪以数据依赖方式获取精确质量全扫描质谱和串联质谱,从而消除对母体质列表的依赖。初始筛选采用高质量容差(约10 ppm)来过滤全扫描质谱数据,以查找先前报道的奈法唑酮代谢物。紧密的质量容差可减少或消除背景化学噪声,显著提高确认或排除代谢物以及等压形式存在的灵敏度。可疑代谢物的全扫描精确质量分析可使用三种主要工具进行确认或反驳:(1)预测化学式和相应的质量误差分析,(2)环加双键分析,以及(3)母体和可疑代谢物的精确质量产物离子谱。母体离子结构的精确质量表征为评估代谢物的结构归属提供了基础。代谢物还通过母体产物离子的m/z值进行表征,以过滤所有串联质谱,用于识别产生相似产物离子的前体离子。已鉴定的代谢物母体质量通过基于精确质量以及键饱和度的化学式计算器进行分析。使用精确质量产物离子谱对潜在的奈法唑酮代谢物进行进一步分析。所有全扫描质谱和串联质谱报告的质量测量误差均<3 ppm,无论相对离子丰度如何,这使得能够使用预测软件来确定产物离子结构。在单次实验运行中,通过串联质谱结合精确质量测量进行生物转化谱分析的能力显然是该方法最具吸引力的特征之一。